The FTC’s recent campaign against private equity roll-ups hit a stumbling block on May 13 as the United States District Court for the Southern District of Texas tossed out the Federal Trade Commission’s antitrust claims...more
On March 5, the FTC convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects the FTC and DOJ Antitrust Division’s recent focus on...more
3/12/2024
/ Acquisitions ,
Anticompetitive Behavior ,
Antitrust Provisions ,
Biden Administration ,
Corporate Practice of Medicine ,
Department of Justice (DOJ) ,
Enforcement Priorities ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Mergers ,
Private Equity ,
Private Equity Firms
On October 17, the United States Senate passed S.2258, the Criminal Antitrust Anti-Retaliation Act of 2019 (“CAARA”). If enacted, it would amend the 2004 Antitrust Criminal Penalty Enhancement and Reform Act, which limited...more
10/24/2019
/ ACPERA ,
Anti-Retaliation Provisions ,
Antitrust Division ,
Antitrust Violations ,
Corporate Counsel ,
Corporate Misconduct ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Dodd-Frank ,
Leniency Programs ,
Whistleblower Protection Policies ,
Whistleblowers ,
White Collar Crimes